Search research articles
Contact Us
Filters
Showing results (181-190 of 407) with videos related to
Page
of 41
Sort By:
European Journal of Immunology
|
February 3, 2006
Endogenous cortisol determines the circadian rhythm of lipopolysaccharide-- but not lipoteichoic acid--inducible cytokine release
Corinna Hermann, Sonja von Aulock, Oliver Dehus, et al.
Journal of Chemical Information and Modeling
|
July 15, 2017
Development and Validation of a Computational Model Ensemble for the Early Detection of BCRP/ABCG2 Substrates during the Drug Design Stage
Melisa E Gantner, Roxana N Peroni, Juan F Morales, et al.
Infection
|
August 26, 2024
Disseminated fusariosis after allogenic hematopoietic stem cell transplantation: case report
A Gantner, J B Hagemann, B Grüner, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 22, 2003
An orally bioavailable small molecule antagonist of CRTH2, ramatroban (BAY u3405), inhibits prostaglandin D2-induced eosinophil migration in vitro
Hiromi Sugimoto, Michitaka Shichijo, Takashi Iino, et al.
Progress in Retinal and Eye Research
|
November 14, 2018
Metabolomics in the study of retinal health and disease
Inês Laíns, Mari Gantner, Salome Murinello, et al.
Antimicrobial Agents and Chemotherapy
|
June 5, 2019
Intravenous Immunoglobulin Administration Significantly Increases BKPyV Genotype-Specific Neutralizing Antibody Titers in Kidney Transplant Recipients
Aurélie Velay, Morgane Solis, Ilies Benotmane, et al.
Heliyon
|
May 20, 2022
Psychological outcomes and support in grandparents whose grandchildren suffer from a severe physical illness: A systematic review
Cristina Priboi, Barbara Gantner, Pauline Holmer, et al.
Mini Reviews in Medicinal Chemistry
|
March 17, 2012
CNS drug development - lost in translation?
A Talevi, C L Bellera, M Di Ianni, et al.
Journal of Neurotrauma
|
December 20, 2017
Temporal Trends in Functional Outcomes after Severe Traumatic Brain Injury: 2006-2015
Ben Beck, Dashiell Gantner, Peter A Cameron, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 2, 2011
Functional and biochemical rationales for the 24-hour-long duration of action of olodaterol
Paola Casarosa, Ines Kollak, Tobias Kiechle, et al.
Page
of 41
Search research articles
Search
Showing results (181-190 of 407) with videos related to
Sort By:
Page
of 41
European Journal of Immunology
|
February 3, 2006
Endogenous cortisol determines the circadian rhythm of lipopolysaccharide-- but not lipoteichoic acid--inducible cytokine release
Corinna Hermann, Sonja von Aulock, Oliver Dehus, et al.
Journal of Chemical Information and Modeling
|
July 15, 2017
Development and Validation of a Computational Model Ensemble for the Early Detection of BCRP/ABCG2 Substrates during the Drug Design Stage
Melisa E Gantner, Roxana N Peroni, Juan F Morales, et al.
Infection
|
August 26, 2024
Disseminated fusariosis after allogenic hematopoietic stem cell transplantation: case report
A Gantner, J B Hagemann, B Grüner, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 22, 2003
An orally bioavailable small molecule antagonist of CRTH2, ramatroban (BAY u3405), inhibits prostaglandin D2-induced eosinophil migration in vitro
Hiromi Sugimoto, Michitaka Shichijo, Takashi Iino, et al.
Progress in Retinal and Eye Research
|
November 14, 2018
Metabolomics in the study of retinal health and disease
Inês Laíns, Mari Gantner, Salome Murinello, et al.
Antimicrobial Agents and Chemotherapy
|
June 5, 2019
Intravenous Immunoglobulin Administration Significantly Increases BKPyV Genotype-Specific Neutralizing Antibody Titers in Kidney Transplant Recipients
Aurélie Velay, Morgane Solis, Ilies Benotmane, et al.
Heliyon
|
May 20, 2022
Psychological outcomes and support in grandparents whose grandchildren suffer from a severe physical illness: A systematic review
Cristina Priboi, Barbara Gantner, Pauline Holmer, et al.
Mini Reviews in Medicinal Chemistry
|
March 17, 2012
CNS drug development - lost in translation?
A Talevi, C L Bellera, M Di Ianni, et al.
Journal of Neurotrauma
|
December 20, 2017
Temporal Trends in Functional Outcomes after Severe Traumatic Brain Injury: 2006-2015
Ben Beck, Dashiell Gantner, Peter A Cameron, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 2, 2011
Functional and biochemical rationales for the 24-hour-long duration of action of olodaterol
Paola Casarosa, Ines Kollak, Tobias Kiechle, et al.
Page
of 41